|
Category
|
Cases
|
Drug resistant†
|
MDR‡
|
|---|
| | |
HR
|
HRE
|
HRS
|
HRSE
| |
|---|
| | |
n(%)
|
n(%)
|
n(%)
|
n(%)
|
n(%)
|
|---|
|
Total
|
1824
|
37(2.03)
|
26(1.43)
|
94(5.15)
|
146(8.00)
|
303(16.61)
|
|
New cases
|
1180
|
9(0.76)
|
5(0.42)
|
33(2.80)
|
43(3.64)
|
90(7.63)
|
|
Previously treated cases
|
644
|
28(4.35)
|
21(3.26)
|
61(9.47)
|
103(15.99)
|
213(33.07)
|
|
χ
2
| |
26.95
|
23.87
|
37.98
|
86.29
|
194.76
|
|
P
| |
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
- †: HR: isoniazid+rifampicin; HRE: isoniazid+rifampicin+ethambutol;
- HRS: isoniazid+rifampicin+streptomycin;
- HRSE: isoniazid+rifampicin+streptomycin+ethambutol
- ‡: MDR, resistant to at least isoniazid and rifampicin
